2026 Agenda

Day 1 – November 5, 2026

Time (ET)	Session Description ∆=Virtual option available
8:15 – 9:00 am	Check-In \| Breakfast
9:00 – 9:20 am	Day 1 Welcome Address Δ Almut G. Winterstein, PhD Consortium for Medical Marijuana Clinical Outcomes Research University of Florida
9:20 – 9:30 am	CCORC 2026 Agenda Overview Δ Amie J. Goodin, PhD Consortium for Medical Marijuana Clinical Outcomes Research University of Florida
9:30 – 10:30 am	*Keynote: Using behavioral economics to understand cannabis use and misuse Δ** Introduction: Amie J. Goodin, PhD, University of Florida James MacKillop, PhD Department of Psychiatry & Behavioral Neurosciences Centre for Addictions Research, Centre for Medicinal Cannabis Research McMaster University
10:30 – 10:45 am	Exhibitor Hall \| Coffee Break
10:45 – 11:45 am	Presentations of Top Abstracts: Medical Cannabis Across the Lifespan: Patient Characteristics, Clinical Outcomes, and Safety Considerations Moderator: Barry Setlow, PhD, University of Florida Nicole E. Smolinski, PhD, University of Florida Assessing Clinical Characteristics among Children Using Medical Marijuana in Florida Medicaid Wen Wen, MS, University of Florida Medical Marijuana Use and Clinical Characteristics of Users among Pregnant Women in Florida Lihi Bar-Lev Schleider, PhD, Tikun Olam Clinical Outcomes and Changes in Concomitant Medication Use Following Initiation of Medical Cannabis Treatment in Patients with Post-Traumatic Stress Disorder: A Six-Month Prospective Cohort Study Masoud Rouhizadeh, PhD, University of Florida Beyond Use Status: Characterizing the Setting and Source of Cannabis Use in Clinical Notes Using Large Language Models
11:45 – 1:15 pm	Poster Session 1 \| Exhibitor Hall \| Networking Lunch Reception Please note that the poster session will begin at 12:15 pm
1:15 – 2:15 pm	*Keynote: To eat or not to eat? Cannabinoid control of food intake and energy metabolism Δ** Introduction: Md Mahmudul Hasan, PhD, University of Florida Nicholas DiPatrizio, PhD Department of Biomedical Sciences UCR Center for Cannabinoid Research University of California Riverside
2:15 – 2:20 pm	Room Transition
2:20 – 3:20 pm	Session A: Cannabis, cognition, and clinical care: From adolescent risk to intervention Patricio Viera Perez, PhD, Florida International University Chase Shankula, MS, University of Wisconsin-Milwaukee Benjelene Sutherland, PhD, Florida International University Kathryn Gex, PhD, Medical University of South Carolina Session B: Cannabis use in aging; vulnerabilities and potential benefits Moderator: Barry Setlow, PhD, University of Florida John S. Markowitz, PharmD, University of Florida Jennifer L. Bizon, PhD, University of Florida Yan Wang, PhD, University of Florida Nicole Ennis, PhD, Florida State University Robert L. Cook, MD, University of Florida
3:20 – 3:30 pm	Exhibitor Hall \| Coffee Break (Room Transition)
3:30 – 5:00 pm	Session A: Cannabinoid Trials Unlocked: From IND to Impact Catalina Lopez-Quintero, PhD, University of Florida Anthony Ferrari, PhD, Sym Sciences, LLC Sheila Austin, MS, University of Florida Karina Villalba, PhD, University of Central Florida Lina M. Velilla Jimenez, MS, University of Florida Session B: Cannabinoids in Cancer Care: From Mechanisms and Delivery to Evidence-Based Dosing Moderator: Sebastian Jugl, PhD, University of Florida Mandip Sachdeva, PhD, Florida A&M University Harold Han, PhD, Vertosa Stephen Zimberg, MD, Nova Southeastern University Justin Kander, MS, Cancer Playbook Terel Newton, MD, Total Pain Relief LLC Session C: The Medical Marijuana Clinical Outcomes Repository (MEMORY): Data Architecture and Hands-on Applications Almut G. Winterstein, PhD \| Md Mahmudul Hasan, PhD \| Arthur N. Rosales, MS \| Nicole E. Smolinski, PhD University of Florida
5:00 – 6:00 pm	Poster Session 2 \| Exhibitor Hall \| Networking Reception Appetizers and refreshments provided

Day 2 – November 6, 2026

Time (EDT)	Session Description ∆=Virtual option available
8:15 – 9:00 am	Check-In \| Breakfast
9:00 – 9:15 am	Day 2 Welcome Address Δ Robert L. Cook, MD Consortium for Medical Marijuana Clinical Outcomes Research University of Florida
9:15 – 10:15 am	Keynote: *Tolerance breaks and other forms of controlled cannabis use: Implications for clinical research and practice Δ** Introduction: Robert L. Cook, MD, University of Florida Stephen Lankenau, PhD Department of Community Health and Prevention Medical Cannabis Research Center Drexel University
10:15 – 10:20 am	Room Transition
10:20 – 11:20 am	Session A: Advancing Medical Cannabis Practice: Integrating Patient, Clinical, Pharmacological, and Policy Perspectives Moderator: Christopher R. McCurdy, PhD, University of Florida Robert Welch, PharmD, University of Mississippi Melani Kane, PharmD, International Society of Cannabis Pharmacists Christine Roussel, PharmD, International Society of Cannabis Pharmacists Session B: Who, What, and How much? Decoding Modern Cannabis Exposure Juan Guillermo Perez Carreno, PhD \| Madelyn Eason \| Tracy Qu \| Andrew Velarde \| Ryan Kalina University of Florida
11:20 – 11:30 am	Exhibitor Hall \| Coffee Break (Room Transition)
11:30 – 12:30 pm	Presentations of Top Abstracts: Medical Cannabis: Patterns of Use, Therapeutic Dosing, and Emerging Therapies Moderator: Mark Kindy, PhD, University of South Florida Sandeep Chary Padakanti, PhD, Florida A&M University Biomimetic Milk Lipid Nanoparticles Outperform Natural Camel Milk-Derived Exosomes for Enhanced Oral Cannabidiol Delivery Marina Alacoque Rodrigues, MS, University of Florida Cannabis Use and Cannabis Use Disorder Among Adult Cancer Survivors in the United States: A Population-Based Cross-Sectional Analysis Terel Newton, MD, Total Pain Relief LLC Is There an Optimal Medical Cannabis Dosage for Cancer Pain? A Focused Analysis of Primary Clinical Studies Mehdi Nouraei, PhD, Micellae Delivery Systems Mucopenetrative intranasal cannabinoid nanoparticles as a steroid-sparing approach for chronic rhinosinusitis(crs)
12:30 – 1:00 pm	Closing and Awards Ceremony Δ
1:00 – 2:00 pm	Board Meeting and Lunch (Invitation Only)

* The three keynote addresses may be eligible for CME and CPE credits.